1990
DOI: 10.1016/0014-5793(90)81084-2
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of a recombinant ricin‐A‐chain fusion protein containing a proteolytically‐cleavable spacer sequence

Abstract: Chimeric proteins composed of ricin toxin A chain (RTA) and staphylococoal protein A (PA) have been produced in E. coii. Construcb consisting of N-terminal RTA and C-terminal PA (RTA-PA) or N-terminal PA and C-terminal (PA-RTA) were capable of binding to immunoglobulin G (via PA) and of specitically depurinating 28 S ribosomal RNA (via RTA). Howevtx, neither fusion protein was cytotoxic to antigen-bearing target cells in the presence of an appropriate monoclonal antibody presumably because the RTA could not be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0

Year Published

1993
1993
2010
2010

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(29 citation statements)
references
References 27 publications
0
29
0
Order By: Relevance
“…A C-terminal Lys-Asp-Glu-Leu sequence (KDEL) was attached by amplifying the BSRNase gene with the C-terminal primer BSRKDEL 5'-CTGGGCGTGGAATTCTTATTACAGTTCGTC-CTTCACTGAAGCATCGAA-3' and the N-terminal primer BSRNXHO. A 22-amino-acid sequence containing the diphtheria toxin disulphide loop (O'Hare et al, 1990) was inserted between the scFv and BSRNase as a XhoVISalI cassette obtained by PCR amplification from clone pRAS50 (R Spooner, unpublished results) using the primers DTLOOPFW 5'-GGCTGACGTCTCGAGATCAAGCGCTCTAGCCTC-GAAGGTGGGTGCGCTGGTAATAG-3' and DTLOOPBK 5'-AATTCGGACGTCGACGTCGAGACCACCGCAAGACA-GGC-3'. Six constructs were made in total, with different permutations of N-terminal linker, C-terminal KDEL and diphtheria toxin disulphide loop.…”
Section: Materials and Methods Materialsmentioning
confidence: 99%
See 1 more Smart Citation
“…A C-terminal Lys-Asp-Glu-Leu sequence (KDEL) was attached by amplifying the BSRNase gene with the C-terminal primer BSRKDEL 5'-CTGGGCGTGGAATTCTTATTACAGTTCGTC-CTTCACTGAAGCATCGAA-3' and the N-terminal primer BSRNXHO. A 22-amino-acid sequence containing the diphtheria toxin disulphide loop (O'Hare et al, 1990) was inserted between the scFv and BSRNase as a XhoVISalI cassette obtained by PCR amplification from clone pRAS50 (R Spooner, unpublished results) using the primers DTLOOPFW 5'-GGCTGACGTCTCGAGATCAAGCGCTCTAGCCTC-GAAGGTGGGTGCGCTGGTAATAG-3' and DTLOOPBK 5'-AATTCGGACGTCGACGTCGAGACCACCGCAAGACA-GGC-3'. Six constructs were made in total, with different permutations of N-terminal linker, C-terminal KDEL and diphtheria toxin disulphide loop.…”
Section: Materials and Methods Materialsmentioning
confidence: 99%
“…The immunotoxins described in this report differ by the addition of sequences designed to improve activity and potentiate the cytotoxicity of the molecule, based upon previous work; the addition of a disulphide-bond-forming loop from diphtheria toxin can greatly increase immunotoxin cytotoxicity (O'Hare et al, 1990) and a 'KDEL' endoplasmic reticulum retention signal can increase ricin immunotoxin cytotoxicity by ten-to 250-fold (Wales et al, 1993). In addition, it has been shown that peptides linking chimaeric molecules can modulate the activity of the molecule .…”
mentioning
confidence: 99%
“…Briefly, the gene for the enzymatically active wild type RTA, kindly provided by Dr. J. Michael Lord, Department of Biology Sciences, University of Warwick, Coventry, U.K. [ 13,14 ], was genetically altered to eliminate both its cytotoxic activity (Y80A) and its ability to induce vascular leak (V76M). This construct was then inserted into pET28a (Novagen, Madison, WI), which relies on kanamycin rather than ampicillin for selection.…”
Section: Vaccine Ricin and Antibodiesmentioning
confidence: 99%
“…e23sFv-TD-tBID consists of an anti-HER2 scFv and the truncated form of Bid. The 10-amino acid DT translocation domain was chosen to link e23sFv and tBID because the proteolytically cleavable spacer was shown to enhance cell-killing activity (38,39). We used a prokaryotic expression system to produce biologically active e23sFv-TD-tBID, which retained the binding specificity for HER2 of the parental scFv and was rapidly internalized into HER2-positive target cells.…”
Section: Discussionmentioning
confidence: 99%